2014
Modern Technical Approaches in Resectional Hepatic Surgery
Michalski CW, Billingsley KG. Modern Technical Approaches in Resectional Hepatic Surgery. Surgical Oncology Clinics Of North America 2014, 24: 57-72. PMID: 25444469, DOI: 10.1016/j.soc.2014.09.007.Peer-Reviewed Original ResearchConceptsLiver resectionLiver surgeryPreoperative portal vein embolizationModern liver surgeryColorectal liver metastasesExtensive liver resectionPreoperative patient selectionPortal vein embolizationGroup of patientsBlood-sparing techniquesOverview of indicationsLiver metastasesPerioperative managementVein embolizationLow morbidityPatient selectionMultimodal treatmentHepatic surgeryResectionAdjunctive techniquesSurgeryModern technical approachesSafe performanceEmbolizationMorbidity
2011
Laparoscopic hepatic resection: Favorable short-term outcomes for colorectal cancer metastases of the left hemiliver.
Enestvedt C, Diggs B, Sheppard B, Orloff S, Billingsley K. Laparoscopic hepatic resection: Favorable short-term outcomes for colorectal cancer metastases of the left hemiliver. Journal Of Clinical Oncology 2011, 29: 347-347. DOI: 10.1200/jco.2011.29.4_suppl.347.Peer-Reviewed Original ResearchShort-term outcomesColorectal cancer metastasisLaparoscopic resectionCRC metastasisLiver resectionLeft liverFavorable short-term outcomesLower intraoperative blood lossCancer metastasisIntraoperative blood lossLaparoscopic liver resectionGroup of patientsLaparoscopy groupLeft hepatectomyTumor factorsBlood lossDisease recurrenceLaparoscopic approachLeft hemiliverMajor complicationsRetrospective reviewTumor characteristicsOpen surgeryOpen groupUnivariate analysis
2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Whitehead R, Rankin C, Hoff P, Gold P, Billingsley K, Chapman R, Wong L, Ward J, Abbruzzese J, Blanke C. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Investigational New Drugs 2008, 27: 469. PMID: 18941712, PMCID: PMC3024913, DOI: 10.1007/s10637-008-9190-8.Peer-Reviewed Original ResearchConceptsMetastatic colorectal cancerColorectal cancerPerformance statusSouthwest Oncology Group studyAdequate bone marrowCombination of romidepsinPrior chemotherapy regimenPrior chemotherapy regimensSignificant cardiac diseaseHuman tumor xenograft modelsAdvanced colorectal cancerPhase II trialColorectal cancer patientsGroup of patientsTreatment of patientsTumor growth inhibitionTumor xenograft modelHistone deacetylase inhibitorsEligible patientsPrior chemotherapyPrior regimensStable diseaseAdvanced diseaseChemotherapy regimenChemotherapy regimens